Market Cap 1.86B
Revenue (ttm) 1.29B
Net Income (ttm) 58.52M
EPS (ttm) N/A
PE Ratio 24.88
Forward PE 17.11
Profit Margin 4.54%
Debt to Equity Ratio 0.00
Volume 4,411,500
Avg Vol 1,603,856
Day's Range N/A - N/A
Shares Out 78.33M
Stochastic %K 99%
Beta 0.91
Analysts Strong Sell
Price Target $27.73

Company Profile

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed d...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 212 888 3124
Address:
1359 Broadway, New York, United States
AdrianCartier
AdrianCartier May. 9 at 6:28 PM
0 · Reply
topstockalerts
topstockalerts May. 8 at 9:29 PM
$PGNY this is how momentum builds… slow then boom
0 · Reply
MarketBeat
MarketBeat May. 8 at 8:03 PM
Progyny Q1 Earnings Call Highlights $PGNY #Progyny #instantalerts #NASDAQ:PGNY https://www.marketbeat.com/instant-alerts/progyny-q1-earning
0 · Reply
_BottomPlays
_BottomPlays May. 8 at 6:16 PM
AMS might be the most bullish smallcap setup. On breakout watch! Make sure to keep eyes on ticker AMS.✅ AMS looking strong right now! ✅ No current dilution ✅ Volume picking up ✅ Momentum building ✅ Clean chart setup ✅ Major contract locked through 2033 ✅ Improving fundamentals $PGNY $TEAD $WALD $JLHL ...1211
0 · Reply
equity_cash_long
equity_cash_long May. 8 at 6:11 PM
$FEMY result out for $PGNY, raises the bar for femasys. pgny is more into corporate IVF packages for late motherhood. hope they don't eye femasys for a MA.
0 · Reply
txbondman
txbondman May. 8 at 2:45 PM
sld some winners (partial) to take profits. sld $CLFD for a 30% gain; sld $INOD for a 90% gain; sld $PGNY for a 20 % gain;
0 · Reply
JFDI
JFDI May. 8 at 1:40 PM
$PGNY we back?
0 · Reply
SkullInferno
SkullInferno May. 7 at 11:48 PM
0 · Reply
SkullInferno
SkullInferno May. 7 at 11:47 PM
$PGNY suii
0 · Reply
capitalthinktank
capitalthinktank May. 7 at 9:29 PM
$PGNY Q1 FY26 delivered a slight beat with stable fundamentals. Revenue $328.5M vs $326M est (+1.4% YoY). Adj. EPS $0.50 vs $0.30 est, a clear upside in profitability. Gross margin held at 25.3% with EBITDA at $56.6M, showing steady cash generation. FY26 guidance: revenue $1.365B–$1.405B (+5.9% to +9% YoY), EPS $1.98–$2.09, indicating steady growth. Q2 outlook: revenue $342M$355M, EPS $0.50–$0.53, in line with current trend. Ops: 7.185M members, 15,647 ART cycles. $225.1M cash, no debt. $116.4M buyback completed in Q1. Overall: steady growth with gradual margin improvement. 👉If this helps, tap @capitalthinktank
0 · Reply
Latest News on PGNY
Progyny price target raised to $29 from $27 at BofA

2026-05-08T11:09:49.000Z - 1 day ago

Progyny price target raised to $29 from $27 at BofA


Progyny reports Q1 adjusted EPS 50c, consensus 44c

2026-05-07T21:24:32.000Z - 2 days ago

Progyny reports Q1 adjusted EPS 50c, consensus 44c


Progyny sees Q2 adjusted EPS 50c-53c, consensus 48c

2026-05-07T21:21:01.000Z - 2 days ago

Progyny sees Q2 adjusted EPS 50c-53c, consensus 48c


Progyny Earnings Call Transcript: Q1 2026

May 7, 2026, 4:45 PM EDT - 2 days ago

Progyny Earnings Call Transcript: Q1 2026


Progyny, Inc. Announces First Quarter 2026 Results

May 7, 2026, 4:01 PM EDT - 2 days ago

Progyny, Inc. Announces First Quarter 2026 Results


Progyny price target lowered to $23 from $29 at Barclays

2026-03-20T09:50:29.000Z - 7 weeks ago

Progyny price target lowered to $23 from $29 at Barclays


Progyny price target lowered to $19 from $26 at Canaccord

2026-03-11T11:10:58.000Z - 2 months ago

Progyny price target lowered to $19 from $26 at Canaccord


Progyny Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 10:40 AM EDT - 2 months ago

Progyny Transcript: Leerink Global Healthcare Conference 2026


Progyny price target lowered to $30 from $35 at BTIG

2026-03-06T12:25:34.000Z - 2 months ago

Progyny price target lowered to $30 from $35 at BTIG


INVO Fertility’s Wisconsin clinic joins Progyny network

2026-03-03T13:53:42.000Z - 2 months ago

INVO Fertility’s Wisconsin clinic joins Progyny network

IVF


Progyny price target lowered to $28 from $34 at Truist

2026-03-02T13:41:10.000Z - 2 months ago

Progyny price target lowered to $28 from $34 at Truist


Progyny price target lowered to $28 from $32 at KeyBanc

2026-03-02T11:59:03.000Z - 2 months ago

Progyny price target lowered to $28 from $32 at KeyBanc


Progyny reports Q4 adjusted EPS 48c, consensus 40c

2026-02-26T21:46:50.000Z - 2 months ago

Progyny reports Q4 adjusted EPS 48c, consensus 40c


Progyny Earnings Call Transcript: Q4 2025

Feb 26, 2026, 4:45 PM EST - 2 months ago

Progyny Earnings Call Transcript: Q4 2025


Progyny sees Q1 adjusted EPS 42c-45c, consensus 50c

2026-02-26T21:44:47.000Z - 2 months ago

Progyny sees Q1 adjusted EPS 42c-45c, consensus 50c


Progyny sees FY26 adjusted EPS $1.83-$1.95, consensus $1.96

2026-02-26T21:42:09.000Z - 2 months ago

Progyny sees FY26 adjusted EPS $1.83-$1.95, consensus $1.96


Progyny, Inc. Announces Fourth Quarter 2025 Results

Feb 26, 2026, 4:01 PM EST - 2 months ago

Progyny, Inc. Announces Fourth Quarter 2025 Results


Progyny price target raised to $35 from $30 at BTIG

2026-01-21T12:20:50.000Z - 3 months ago

Progyny price target raised to $35 from $30 at BTIG


Progyny upgraded to Outperform from Market Perform at Citizens

2026-01-20T09:45:15.000Z - 3 months ago

Progyny upgraded to Outperform from Market Perform at Citizens


Progyny Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 10:30 AM EST - 4 months ago

Progyny Transcript: 44th Annual J.P. Morgan Healthcare Conference


Progyny upgraded to Buy from Hold at Truist

2026-01-08T14:25:40.000Z - 4 months ago

Progyny upgraded to Buy from Hold at Truist


Does Progyny Stock Lead The Pack?

Nov 18, 2025, 11:10 AM EST - 6 months ago

Does Progyny Stock Lead The Pack?


Progyny Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 10:00 AM EST - 6 months ago

Progyny Transcript: Jefferies London Healthcare Conference 2025


Progyny, Inc. to Present at Jefferies Global Healthcare Conference

Nov 13, 2025, 12:33 PM EST - 6 months ago

Progyny, Inc. to Present at Jefferies Global Healthcare Conference


Progyny Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:45 PM EST - 6 months ago

Progyny Earnings Call Transcript: Q3 2025


Progyny, Inc. Announces Third Quarter 2025 Results

Nov 6, 2025, 4:01 PM EST - 6 months ago

Progyny, Inc. Announces Third Quarter 2025 Results


Progyny Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:45 PM EDT - 9 months ago

Progyny Earnings Call Transcript: Q2 2025


Progyny, Inc. Announces Second Quarter 2025 Results

Aug 7, 2025, 4:02 PM EDT - 9 months ago

Progyny, Inc. Announces Second Quarter 2025 Results


Progyny Transcript: AGM 2025

May 22, 2025, 3:00 PM EDT - 1 year ago

Progyny Transcript: AGM 2025


Progyny Earnings Call Transcript: Q1 2025

May 8, 2025, 4:45 PM EDT - 1 year ago

Progyny Earnings Call Transcript: Q1 2025


Progyny, Inc. Announces First Quarter 2025 Results

May 8, 2025, 4:14 PM EDT - 1 year ago

Progyny, Inc. Announces First Quarter 2025 Results


Progyny Transcript: KeyBanc Annual Healthcare Forum 2025

Mar 19, 2025, 2:15 PM EDT - 1 year ago

Progyny Transcript: KeyBanc Annual Healthcare Forum 2025


Progyny Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:45 PM EST - 1 year ago

Progyny Earnings Call Transcript: Q4 2024


Progyny, Inc. Announces Fourth Quarter 2024 Results

Feb 27, 2025, 4:01 PM EST - 1 year ago

Progyny, Inc. Announces Fourth Quarter 2024 Results


Progyny Earnings Call Transcript: Q3 2024

Nov 12, 2024, 4:45 PM EST - 1 year ago

Progyny Earnings Call Transcript: Q3 2024


Progyny, Inc. Announces Third Quarter 2024 Results

Nov 12, 2024, 4:02 PM EST - 1 year ago

Progyny, Inc. Announces Third Quarter 2024 Results


AdrianCartier
AdrianCartier May. 9 at 6:28 PM
0 · Reply
topstockalerts
topstockalerts May. 8 at 9:29 PM
$PGNY this is how momentum builds… slow then boom
0 · Reply
MarketBeat
MarketBeat May. 8 at 8:03 PM
Progyny Q1 Earnings Call Highlights $PGNY #Progyny #instantalerts #NASDAQ:PGNY https://www.marketbeat.com/instant-alerts/progyny-q1-earning
0 · Reply
_BottomPlays
_BottomPlays May. 8 at 6:16 PM
AMS might be the most bullish smallcap setup. On breakout watch! Make sure to keep eyes on ticker AMS.✅ AMS looking strong right now! ✅ No current dilution ✅ Volume picking up ✅ Momentum building ✅ Clean chart setup ✅ Major contract locked through 2033 ✅ Improving fundamentals $PGNY $TEAD $WALD $JLHL ...1211
0 · Reply
equity_cash_long
equity_cash_long May. 8 at 6:11 PM
$FEMY result out for $PGNY, raises the bar for femasys. pgny is more into corporate IVF packages for late motherhood. hope they don't eye femasys for a MA.
0 · Reply
txbondman
txbondman May. 8 at 2:45 PM
sld some winners (partial) to take profits. sld $CLFD for a 30% gain; sld $INOD for a 90% gain; sld $PGNY for a 20 % gain;
0 · Reply
JFDI
JFDI May. 8 at 1:40 PM
$PGNY we back?
0 · Reply
SkullInferno
SkullInferno May. 7 at 11:48 PM
0 · Reply
SkullInferno
SkullInferno May. 7 at 11:47 PM
$PGNY suii
0 · Reply
capitalthinktank
capitalthinktank May. 7 at 9:29 PM
$PGNY Q1 FY26 delivered a slight beat with stable fundamentals. Revenue $328.5M vs $326M est (+1.4% YoY). Adj. EPS $0.50 vs $0.30 est, a clear upside in profitability. Gross margin held at 25.3% with EBITDA at $56.6M, showing steady cash generation. FY26 guidance: revenue $1.365B–$1.405B (+5.9% to +9% YoY), EPS $1.98–$2.09, indicating steady growth. Q2 outlook: revenue $342M$355M, EPS $0.50–$0.53, in line with current trend. Ops: 7.185M members, 15,647 ART cycles. $225.1M cash, no debt. $116.4M buyback completed in Q1. Overall: steady growth with gradual margin improvement. 👉If this helps, tap @capitalthinktank
0 · Reply
LotiDoti
LotiDoti May. 7 at 9:04 PM
0 · Reply
SirSloth
SirSloth May. 7 at 8:55 PM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 8:42 PM
$PGNY Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.30 up 66.67% YoY • Reported revenue of $328.5M up 1.38% YoY • Progyny projects full-year 2026 revenue between $1.37B and $1.41B, reflecting 5.9% to 9.0% growth. Net income is projected to be $103.7M to $112.3M for the full year.
0 · Reply
SirSloth
SirSloth Apr. 20 at 9:02 PM
$PGNY @JFDI 👀👶
1 · Reply
GordoHLYK13
GordoHLYK13 Apr. 17 at 7:53 PM
$AMWL $DCGO $HCAT $PGNY $TDOC $DCGO sitting around $0.64 .65 while data-driven valuations still point near $2.10 means the market is pricing in fear, not fundamentals. If low-ball analyst games fade and buyout value gets recognized, this stock looks like a deep discount setup with serious upside from these levels.
0 · Reply
Nuclear_Elvis
Nuclear_Elvis Apr. 17 at 5:25 PM
$DCGO Quick scan of every data-driven Valuation, shows this about DCGO today. When I last checked after earnings, the data-driven valuation was pegged at $2.50 but on a recheck today, the data report has it lowered to $2.10 and I can see why, and it boils down to lowered Analyst projections. The recent Analyst $1 price target was intentional - to harm DocGo's valuation at a time they are "for sale." Beware the intentions of these so-called professionals. There were low-ball annual revenue estimates from a couple analysts for 2026 (as if DCGO misses earnings for every quarter of the year). Another discriminator - the way peer companies get used for comparison. $PGNY, $AMWL, $TDOC, and $HCAT were data peers (are any truly peers? Debatable). That placed DCGO tied for last among the 5, but - ownership interest of each analyst, in each stock, was not disclosed. How can you make statistics lie? Insert a "peer" whose data fits your narrative and/or insert an analyst projection that does.
1 · Reply
txbondman
txbondman Apr. 10 at 2:38 PM
bot $PGNY to double down. (Don't try this at home!!)
0 · Reply
CaptainAmrica
CaptainAmrica Apr. 8 at 9:21 PM
$PGNY... Bot more...
0 · Reply
macroaxis
macroaxis Apr. 3 at 4:23 AM
$PGNY - Volatility alert: Progyny options pin risk is increasing https://www.macroaxis.com/stock-options/PGNY/Progyny?utm_source=dlvr.it&utm_medium=stocktwits
0 · Reply
tilance
tilance Mar. 25 at 3:02 PM
$PGNY opened a position here today...
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 4:19 PM
$PGNY RSI: 26.85, MACD: -1.4285 Vol: 1.73, MA20: 19.18, MA50: 22.41 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
alwaysanoriolefan
alwaysanoriolefan Mar. 7 at 4:28 PM
$PGNY Anything under $20 seems like an excellent deal! Picked up 2000 shares under $18 this week.
0 · Reply